These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17135586)

  • 21. Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.
    AAMC Task Force on Financial Conflicts of Interest in Clinical Research
    Acad Med; 2003 Feb; 78(2):225-36. PubMed ID: 12584106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
    Puttagunta PS; Caulfield TA; Griener G
    Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conflict of interest in the debate over calcium-channel antagonists.
    Stelfox HT; Chua G; O'Rourke K; Detsky AS
    N Engl J Med; 1998 Jan; 338(2):101-6. PubMed ID: 9420342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants.
    Friedman JY; Sugarman J; Dhillon JK; Depuy V; Pierre CK; Dinan MA; Allsbrook JS; Schulman KA; Weinfurt KP
    Clin Trials; 2007; 4(3):272-8. PubMed ID: 17715256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
    Klanica K
    J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors.
    Mello MM; Clarridge BR; Studdert DM
    Account Res; 2005; 12(3):163-91. PubMed ID: 16634168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Medicine: conflicts of interest in research].
    Fallena-Zonana M; Kraus-Weisman A
    Rev Invest Clin; 2003; 55(3):339-46. PubMed ID: 14515679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing financial conflicts of interest.
    IRB; 2003; 25(1):7. PubMed ID: 12833898
    [No Abstract]   [Full Text] [Related]  

  • 30. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
    J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting.
    Hall MA; Friedman JY; King NM; Weinfurt KP; Schulman KA; Sugarman J
    Acad Med; 2010 Oct; 85(10):1554-6. PubMed ID: 20881671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential research participants' views regarding researcher and institutional financial conflicts of interest.
    Kim SY; Millard RW; Nisbet P; Cox C; Caine ED
    J Med Ethics; 2004 Feb; 30(1):73-9. PubMed ID: 14872080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethical challenges to the integrity of physicians: financial conflicts of interest in clinical research.
    Solyom AE
    Account Res; 2004; 11(2):119-39. PubMed ID: 15675053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.
    Henry D; Doran E; Kerridge I; Hill S; McNeill PM; Day R
    Arch Intern Med; 2005 Nov; 165(21):2493-6. PubMed ID: 16314546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethics. Senate inquiry on research conflicts shifts to grantees.
    Kaiser J
    Science; 2008 Jun; 320(5884):1708. PubMed ID: 18583586
    [No Abstract]   [Full Text] [Related]  

  • 38. Science on trial: conflicts of interest jeopardize scientific integrity and public health.
    Krimsky S
    Genewatch; 2003; 16(5):3-6. PubMed ID: 15025119
    [No Abstract]   [Full Text] [Related]  

  • 39. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Policies on faculty conflicts of interest at US universities.
    Cho MK; Shohara R; Schissel A; Rennie D
    JAMA; 2000 Nov; 284(17):2203-8. PubMed ID: 11056591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.